---
type: ProjectLayout
title: Machine Learning-Based Predictive Model for Diabetic Nephropathy
colors: colors-a
date: '2024-06-01'
client: Awesome client
description: >-
  It’s hard to imagine that I’ve that I wrote all this code by myself, probably
  because I worked with an entire team :) but they definitely followed my lead
  most of the time.
---
The **Machine Learning-Based Predictive Model for Diabetic Nephropathy** is a complex research endeavor that seeks to predict the severity of diabetic nephropathy through the integration of gene polymorphisms and serum biomarkers. Diabetic nephropathy, a severe complication of diabetes, can result in end-stage renal disease if it is not detected and treated in its early stages. This endeavor utilizes the capabilities of machine learning to improve early detection and deliver personalized management approaches for patients.

The main aim of this project was to create a sophisticated predictive model that combines clinical and genotypic information to successfully evaluate the severity of the disease. The data set consisted of gene polymorphisms and important serum markers such as creatinine and albumin, which are particularly recognized for their effectiveness in maintaining kidney function. The machine learning algorithms employed in this research were **Random Forest**, **Support Vector Machine (SVM)**, and **Logistic Regression**, all of which were chosen for their strength in processing intricate biomedical data. Extensive preprocessing and feature engineering were involved in the development stage to maintain high model accuracy and reliability. Data exploratory analysis uncovered key findings, including that serum creatinine concentration correlated very strongly with disease severity, hence emerging as the most critical predictor. Albumin and specific genetic markers were also found to be important contributors, indicating the need to incorporate both genetic and clinical features.

Out of the models evaluated, the **Random Forest** model performed best with an **accuracy of 84.75%**. The model's ability to deal with non-linearity and resistance to overfitting are responsible for the high accuracy. For better understanding the predictions of the model, **SHAP (SHapley Additive exPlanations)** was employed, offering insight into feature importance and assisting with model explainability.

This project not only proves the efficacy of machine learning in predictive healthcare but also depicts the significance of integrating clinical and genetic information to make accurate diagnoses. The results show the significance of serum creatinine as a leading biomarker while highlighting the impact of genetic drivers in disease development. By making early detection possible and allowing for personalized treatment plans, this predictive model contributes to enhanced patient outcomes and a clearer grasp of diabetic nephropathy.

In total, this research project demonstrates the potential of AI and machine learning in medicine, opening doors for future research that incorporates multi-dimensional data for improved disease prediction and management.
